N-(4-bromophenyl) 3-(4-bromophenylaminosulfonyl)benzamide
lead compound for drugs to treat Huntington's disease; structure in first source
Also Known As:
C2-8 compound
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results